Found: 23
Select item for more details and to access through your institution.
Segmental Considerations in Colonoscopy Recommendations for Investigating Focal Colonic FDG Activity on PET/CT.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Gallium-68 DOTA-TATE Positron Emission Tomography/Computed Tomography: Scintigraphic Changes of Adrenal Glands Following Management of Ectopic Cushing's Syndrome by Steroidogenesis Inhibitors.
- Published in:
- World Journal of Nuclear Medicine, 2014, v. 13, n. 3, p. 201, doi. 10.4103/1450-1147.144823
- By:
- Publication type:
- Article
A role of PSMA PET/CT in multimodality imaging approach in adenoid cystic carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Unraveling the Impact of <sup>177</sup>Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 85, doi. 10.2967/jnumed.123.266638
- By:
- Publication type:
- Article
Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1748, doi. 10.2967/jnumed.123.266025
- By:
- Publication type:
- Article
Could FAP-Targeted Molecular Imaging Replace <sup>18</sup>F-FDG for Standard-of-Care Oncologic PET?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 623, doi. 10.2967/jnumed.122.265003
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma: PRRT Efficacy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 1, p. 1, doi. 10.2967/jnumed.119.237990
- By:
- Publication type:
- Article
Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.
- Published in:
- Respirology, 2015, v. 20, n. 1, p. 129, doi. 10.1111/resp.12409
- By:
- Publication type:
- Article
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2322, doi. 10.1007/s00259-020-04723-z
- By:
- Publication type:
- Article
The added benefit of contrast-enhanced CT in evaluation of incidental FDG-avid colon lesions.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1902, doi. 10.1007/s00259-019-04389-2
- By:
- Publication type:
- Article
Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article